Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Management of Bronchospasm with Magnesium Sulfate

Indications and Efficacy

  • IV magnesium sulfate is recommended for patients with severe bronchospasm that remains severe after 1 hour of intensive conventional treatment, providing a complementary bronchodilator effect to standard treatments, according to the American College of Physicians 1
  • Magnesium causes relaxation of bronchial smooth muscle independent of serum magnesium level 1
  • In severe cases of bronchospasm, magnesium sulfate should be considered as part of the secondary management approach, as suggested by the American Society of Anesthesiologists 2

Treatment Algorithm

  • First-line treatment should include short-acting beta-agonists (SABAs), anticholinergics if needed, and systemic corticosteroids for significant bronchospasm, as recommended by the American Academy of Allergy, Asthma, and Immunology 3, 4
  • If bronchospasm remains severe after initial treatment, consider IV magnesium sulfate 2g over 20 minutes, as suggested by the American College of Physicians 1

Evidence of Effectiveness

  • Multiple studies demonstrate that IV magnesium sulfate can reduce hospital admissions in patients with severe asthma exacerbations, with a moderate strength of evidence, according to the American College of Physicians 1